| Announce Date | 12/31/1969 |
| EPS Normalized Actual | $ In Line |
| EPS GAAP Actual | $ In Line |
| Revenue Actual | $0B |
| Revenue Surprise | Beat by $0M |
| Announce Date | 03/31/2026 (Pre-Market) |
| EPS Normalized Estimate | $-1.92 |
| EPS GAAP Estimate | $-1.92 |
| Revenue Estimate | $0.0002B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2025 | 0 | INF | 0 | 0 | 0 |
| Dec 2024 | 0 | INF | 0 | 0 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ1 2017 (Mar 2017) | -44.1 | -44.1 | 0B | NAN% | 0M |
| FQ2 2017 (Jun 2017) | -44.1 | -44.1 | 0B | NAN% | 0M |
| FQ1 2018 (Mar 2018) | -102.6 | -102.6 | 0B | NAN% | 0M |
| FQ2 2018 (Jun 2018) | -102.6 | -102.6 | 0B | NAN% | 0M |
| FQ1 2025 (Mar 2025) | -0.0564 | -0.0564 | 0.0001185B | -221.1% | 0.12M |
| FQ2 2025 (Jun 2025) | -0.0564 | -0.0564 | 0.0001185B | -221.1% | 0.12M |
| FQ3 2024 (Sep 2024) | -0.15 | -0.15 | 0.0002695B | 47.31% | 0.27M |
| FQ4 2024 (Dec 2024) | -0.15 | -0.15 | 0.0002695B | 100% | 0.27M |
FQ4 Announce Date
03/31/2026 (Pre-Market)
Consensus EPS Estimates
-1.92
Consensus Revenue Estimates
0.0002B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2027 (Sep 2027) | -1.28 | -- | -1.28 | -1.28 | 1 |
| FQ2 2027 (Jun 2027) | -1.28 | -- | -1.28 | -1.28 | 1 |
| FQ1 2027 (Mar 2027) | -1.28 | -- | -1.28 | -1.28 | 1 |
| FQ4 2026 (Dec 2026) | -1.28 | -- | -1.28 | -1.28 | 1 |
| FQ3 2026 (Sep 2026) | -1.28 | -- | -1.28 | -1.28 | 1 |
| FQ2 2026 (Jun 2026) | -1.36 | 95.85 | -1.36 | -1.36 | 1 |
| FQ1 2026 (Mar 2026) | -1.92 | 97.06 | -1.92 | -1.92 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2027 (Sep 2027) | 0B | -- | 0B | 0B | 1 |
| FQ2 2027 (Jun 2027) | 0B | -- | 0B | 0B | 1 |
| FQ1 2027 (Mar 2027) | 0B | -- | 0B | 0B | 1 |
| FQ4 2026 (Dec 2026) | 0B | -- | 0B | 0B | 1 |
| FQ3 2026 (Sep 2026) | 0B | -- | 0B | 0B | 1 |
| FQ2 2026 (Jun 2026) | 0B | 40.75 | 0B | 0B | 1 |
| FQ1 2026 (Mar 2026) | 0B | 40.75 | 0B | 0B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
8
EPS # of in-lines
0
Revenue # of Beats
4
Revenue # of Misses
0
Revenue # of in-lines
4
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ1 2017 (Mar 2017) | -44.1 | -44.1 | 100% | |
| FQ2 2017 (Jun 2017) | -44.1 | -44.1 | 100% | |
| FQ1 2018 (Mar 2018) | -102.6 | -102.6 | 100% | |
| FQ2 2018 (Jun 2018) | -102.6 | -102.6 | 100% | |
| FQ1 2025 (Mar 2025) | -0.0564 | -0.0564 | 100% | |
| FQ2 2025 (Jun 2025) | -0.0564 | -0.0564 | 100% | |
| FQ3 2024 (Sep 2024) | -0.15 | -0.15 | 100% | |
| FQ4 2024 (Dec 2024) | -0.15 | -0.15 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ1 2017 (Mar 2017) | $0B | $0B | $0M | NAN% |
| FQ2 2017 (Jun 2017) | $0B | $0B | $0M | NAN% |
| FQ1 2018 (Mar 2018) | $0B | $0B | $0M | NAN% |
| FQ2 2018 (Jun 2018) | $0B | $0B | $0M | NAN% |
| FQ1 2025 (Mar 2025) | $0B | $0B | $0.12M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $0B | $0.12M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0B | $0.27M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0B | $0.27M | 100% |